Carisma Therapeutics Statistics
Total Valuation
CARM has a market cap or net worth of $34.92 million. The enterprise value is $11.19 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CARM has 41.75 million shares outstanding. The number of shares has increased by 71.70% in one year.
Current Share Class | 41.75M |
Shares Outstanding | 41.75M |
Shares Change (YoY) | +71.70% |
Shares Change (QoQ) | +0.11% |
Owned by Insiders (%) | 12.24% |
Owned by Institutions (%) | 13.38% |
Float | 22.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.75 |
Forward PS | 1.93 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.55 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.23
Current Ratio | 3.23 |
Quick Ratio | 2.66 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -362.79% and return on invested capital (ROIC) is -202.41%.
Return on Equity (ROE) | -362.79% |
Return on Assets (ROA) | -56.08% |
Return on Capital (ROIC) | -202.41% |
Revenue Per Employee | $189,421 |
Profits Per Employee | -$596,262 |
Employee Count | 107 |
Asset Turnover | 0.27 |
Inventory Turnover | n/a |
Taxes
Income Tax | -197,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.37% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -65.37% |
50-Day Moving Average | 0.98 |
200-Day Moving Average | 1.43 |
Relative Strength Index (RSI) | 32.25 |
Average Volume (20 Days) | 191,915 |
Short Selling Information
The latest short interest is 857,538, so 2.05% of the outstanding shares have been sold short.
Short Interest | 857,538 |
Short Previous Month | 1.05M |
Short % of Shares Out | 2.05% |
Short % of Float | 3.77% |
Short Ratio (days to cover) | 8.10 |
Income Statement
In the last 12 months, CARM had revenue of $20.27 million and -$63.80 million in losses. Loss per share was -$1.55.
Revenue | 20.27M |
Gross Profit | -43.24M |
Operating Income | -66.77M |
Pretax Income | -72.70M |
Net Income | -63.80M |
EBITDA | -63.37M |
EBIT | -66.77M |
Loss Per Share | -$1.55 |
Full Income Statement Balance Sheet
The company has $28.13 million in cash and $3.32 million in debt, giving a net cash position of $24.81 million or $0.59 per share.
Cash & Cash Equivalents | 28.13M |
Total Debt | 3.32M |
Net Cash | 24.81M |
Net Cash Per Share | $0.59 |
Equity (Book Value) | -11.13M |
Book Value Per Share | -0.27 |
Working Capital | 23.58M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$67.66 million and capital expenditures -$684,000, giving a free cash flow of -$68.35 million.
Operating Cash Flow | -67.66M |
Capital Expenditures | -684,000 |
Free Cash Flow | -68.35M |
FCF Per Share | -$1.64 |
Full Cash Flow Statement Margins
Gross Margin | -213.35% |
Operating Margin | -329.46% |
Pretax Margin | -315.75% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -369.45% |
Dividends & Yields
CARM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -71.70% |
Shareholder Yield | -71.70% |
Earnings Yield | -177.20% |
FCF Yield | -189.82% |
Dividend Details Analyst Forecast
The average price target for CARM is $12.67, which is 1,414.64% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.67 |
Price Target Difference | 1,414.64% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | -3.56% |
EPS Growth Forecast (5Y) | -5.55% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CARM has an Altman Z-Score of -12.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -12.76 |
Piotroski F-Score | 2 |